Abstract
The effects of sex, the menstrual cycle, oral contraceptives, pregnancy, and the menopause on skin perfusion in healthy women and in patients with Raynaud's phenomenon suggest a role of female sex hormones. However, no clear relation between skin blood flow and circulating concentrations of oestrogens or progestogens has yet been found. The aim of this study was to investigate the effect of orally administered 17β-oestradiol and progesterone on finger skin blood flow before and during heat and cold challenge in 17 healthy normotensive women and in 12 women with Raynaud's phenomenon.
In each subject standardized finger heating (45°;C water bath, 10 min) and cooling tests (15°;C water bath, 5 min and 20 min recovery) were performed twice on the second (or third) day of two consecutive menstrual cycles. 17β-Oestradiol (9 mg) or progesterone (300 mg) were given before the second test, after a first test with placebo. Both hormonal doses resulted in (high) physiological concentrations. Fingertip skin temperature and laser Doppler flux were measured.
There were no significant differences in the test results after placebo and after progesterone. Although values of fingertip skin temperature and laser Doppler flux after 17β-oestradiol tended to be higher only the precooling values in the healthy subjects reached significance: fingertip skin temperature respectively with placebo and with oestradiol (mean (SD)): 32.7 (1.0) and 33.1 (0.8)°;C; laser Doppler flux with placebo and with oestradiol: 33.6 (11.7) and 42.2 (9.5) perfusion units; both P<0.05). In this study, single oral doses of female sex hormones had only minor effects on finger skin circulation, both in control subjects and in women with Raynaud's phenomenon.
This is a preview of subscription content, log in via an institution to check access.
References
Altura BM, Altura BT (1977) Influence of sex hormones, oral contraceptives and pregnancy on vascular muscle and its reactivity. In: Carrier O, Shibata S (eds) Factors influencing vascular reactivity. Igaku-Shoin, Tokyo, pp 221–254
Cooke JP, Creager MA, Osmundson PJ, Shepherd JT (1990) Sex differences in the control of cutaneous blood flow. Circulation 82: 1607–1615
Van de Wal HJCM, Wijn PFF, van Lier HJJ, Kneepkens WGHJ, Skotnicki SH (1987) Noninvasive hemodynamic assessment of vasospasm in patients with primary Raynaud's phenomenon. Angiology 38: 315–332
Bartelink ML, Wollersheim H, Theeuwes A, Duren D van, Thien T (1990) Changes in skin blood flow during the menstrual cycle: the influence of the menstrual cycle on the peripheral circulation in healthy female volunteers. Clin Sci 78: 527–532
Tooke JE, Tindall H, McNicol GP (1981) The influence of a combined oral contraceptive pill and menstrual cycle phase on digital microvascular haemodynamics. Clin Sci 61: 91–95
Katz M, Sokal MM (1980) Skin perfusion in pregnancy. Am J Obstet Gynecol 137: 30–33
Gifford RW, Hines EA (1957) Raynaud's disease among women and girls. Circulation 16: 1012–1021
Wollersheim H, Thien Th (1990) The diagnostic value of clinical signs and symptoms in patients with Raynaud's phenomenon. A cross-sectional study. Neth J Med 37: 171–182
Allen EV, Brown GE (1932) Raynaud's disease, a critical review of minimal requisites for diagnosis. Am J Med Sci 183: 187–200
Wollersheim H, Thien T, Hoet MH, Venrooy WJ van (1989) The diagnostic value of several immunological tests for anti-nuclear antibody in predicting the development of connective tissue disease in patients presenting with Raynaud's phenomenon. Eur J Clin Invest 19: 535–541
Bartelink ML, De Wit A, Wollersheim H, Theeuwes A, Thien T (1993) Skin vascular reactivity in healthy subjects: influence of hormonal status. J Appl Physiol 74: 727–732
Thomas CMG, Corbey RS, Rolland R (1977) Assessment of unconjugated oestradiol and progesterone levels throughout pregnancy in normal women and in women with hyperprolactinaemia who conceived after bromocriptine treatment. Acta Endocrinol 86: 405–414
Kremer JAM, Borm G, Schellekens LA, Thomas CMG, Rolland R (1991) Pulsatile secretion of luteinizing hormone and prolactin in lactating and nonlactating women and the response to naltrexone. J Clin Endocrinol Metab 72: 294–300
Bartelink ML, Wollersheim H, Jansen RWMM, Theeuwes A, Thien T (1993) Reproducibility of the finger cooling test. Microvasc Res 45: 65–73
Campisi D, Bivona A, Paterna S, Valenza M, Albiero R (1987) Oestrogen binding sites in fresh human aortic tissue. Int J Tiss React 9: 393–398
Ingegno MD, Money SR, Thelmo W, Greene GL, Davidian M, Jaffe B, Pertschuk LP (1988) Progesterone receptors in the human heart and the great vessels. Lab Invest 59: 353–356
Solerte SB, Fioravanti M, Spinillo A, Ferrari E, Guaschino S (1988) Association between hormonal and haemorheological changes during the menstrual cycle in healthy women. Br J Obstet Gynaecol 95: 1305–1308
Freedman RR, Sabharwal SC, Desai N (1987) Sex differences in peripheral vascular adrenergic receptors. Circ Res 61: 581–585
Jones SB, Bylund DB, Rieser CA, Shekim WO, Beyer JA, Carr GW (1983) α2-Adrenergic receptor binding in human platelets: alterations during the menstrual cycle. Clin Pharmacol Ther 34: 90–96
Sundaresan PR, Madan MK, Kelvie SL, Weintraub M (1985) Platelet α2adrenoceptors and the menstrual cycle. Clin Pharmacol Ther 37: 337–342
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bartelink, M.L., Wollersheim, H., Vemer, H. et al. The effects of single oral doses of 17β-oestradiol and progesterone on finger skin circulation in healthy women and in women with primary Raynaud's phenomenon. Eur J Clin Pharmacol 46, 557–560 (1994). https://doi.org/10.1007/BF00196115
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00196115